Clinical trial
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
NCT00049075 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00049075 |
|---|---|
| Title | Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia |
| Official title | A Phase II Study of Oral Fludarabine Phosphate in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | fludarabine phosphate |
| Enrollment | 128 |
| Start date | Aug 8, 2002 |
| Primary completion | Jul 22, 2005 |
| Completion | Dec 21, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 6, 2020 |
| Countries | Canada, France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: